MY ACCOUNT | NEWSLETTER |

Effects of transdermal mirtazapine and oral gabapentin as pre-vet visit pharmaceuticals for shelter cats


Humane medical handling of fearful felines in the shelter is a challenge for staff. Gabapentin has entered into clinical use to attenuate fear and anxiety in cats during handling, but restraint for pilling can be dangerous for the handler and contribute to fear responses in the cat.

Administering pre-veterinary visit pharmaceuticals to cats with minimal stress remains elusive. Transdermal medications, which require minimal handling, may improve compliance.

While no transdermal anxiolytics have shown a sufficient pharmacodynamic effect in cats, transdermal mirtazapine has entered into use for appetite stimulation.

This double-blinded, placebo-controlled study assessed the effect of transdermal mirtazapine on the amount of gabapentin-laced food ingested, and the effect of gabapentin on signs of fear and anxiety in cats when handled for examination.

To test this, 94 healthy shelter cats were randomly assigned to one of five treatment groups. Data collected by the team included the amount of food consumed, estimated gabapentin dose consumed where applicable, and physiologic and behavioral parameters during examination.

Cats pre-treated with transdermal placebo consumed significantly less gabapentin-laced food than cats pre-treated with transdermal mirtazapine.

While there was a significant inverse relationship between estimated gabapentin dose consumed and heart rate and respiratory rate, the addition of transdermal mirtazapine counteracted these effects. No other significant relationships were found between treatments and the remaining measurements.

While pre-treatment transdermal mirtazapine allowed for easier administration of gabapentin, its stimulating effects may have counteracted gabapentin’s anxiolytic effects. Future research should investigate reliable, minimally stressful methods for administering pre-veterinary visit pharmaceuticals to shelter cats.

Vanessa Spano, Cary M. Springer, E’Lise Christensen, Julia D. Albright, "Effects of transdermal mirtazapine and oral gabapentin as pre-veterinary visit pharmaceuticals for shelter cats," Journal of Veterinary Behavior, Volumes 64–65, 2023, Pages 47-53, ISSN 1558-7878, https://doi.org/10.1016/j.jveb.2023.06.001.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Ethical issues in geriatric feline medicine

Like0
Dislike0

The future of canine glaucoma therapy

Like0
Dislike0

Impact of antibiotic use in the swine industry

Like0
Dislike0

WSU researchers join $9.6M push to fight Rift Valley fever

Like0
Dislike0

PetPace™ Launches World's First AI Smart Collar that Includes 24/7 Global Telehealth and Telemedicine—Revolutionizing Real-Time Health Monitoring for Dogs and Cats

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top